Show
Sort by
-
Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis
-
Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10
-
Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice
-
A "universal" human influenza A vaccine
-
Morphological study of interleukin-10 producing Lactococcus Lactis in mouse ileal loops
-
Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
-
Soluble recombinant influenza vaccines
(2001) PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES. 356(1416). p.1961-1963 -
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
-
A universal influenza A vaccine based on the extracellular domain of the M2 protein.
-
Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin.